- Home
- MSGE vs NVAX Comparison
MSGE vs NVAX Comparison
Compare MSGE & NVAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MSGE
- NVAX
- Stock Information
- Founded
- MSGE 2020
- NVAX 1987
- Country
- MSGE United States
- NVAX United States
- Employees
- MSGE N/A
- NVAX N/A
- Industry
- MSGE Services-Misc. Amusement & Recreation
- NVAX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- MSGE Consumer Discretionary
- NVAX Health Care
- Exchange
- MSGE Nasdaq
- NVAX Nasdaq
- Market Cap
- MSGE 2.1B
- NVAX 2.0B
- IPO Year
- MSGE N/A
- NVAX 1995
- Fundamental
- Price
- MSGE $34.42
- NVAX $9.00
- Analyst Decision
- MSGE Strong Buy
- NVAX Buy
- Analyst Count
- MSGE 5
- NVAX 6
- Target Price
- MSGE $46.00
- NVAX $17.83
- AVG Volume (30 Days)
- MSGE 448.6K
- NVAX 3.6M
- Earning Date
- MSGE 02-05-2025
- NVAX 11-12-2024
- Dividend Yield
- MSGE N/A
- NVAX N/A
- EPS Growth
- MSGE 330.95
- NVAX N/A
- EPS
- MSGE 3.66
- NVAX N/A
- Revenue
- MSGE $955,767,000.00
- NVAX $885,193,000.00
- Revenue This Year
- MSGE $2.13
- NVAX N/A
- Revenue Next Year
- MSGE $5.13
- NVAX N/A
- P/E Ratio
- MSGE $9.43
- NVAX N/A
- Revenue Growth
- MSGE 12.81
- NVAX N/A
- 52 Week Low
- MSGE $30.10
- NVAX $3.53
- 52 Week High
- MSGE $44.14
- NVAX $23.86
- Technical
- Relative Strength Index (RSI)
- MSGE 33.10
- NVAX 50.66
- Support Level
- MSGE $36.57
- NVAX $8.13
- Resistance Level
- MSGE $37.72
- NVAX $9.75
- Average True Range (ATR)
- MSGE 0.98
- NVAX 0.47
- MACD
- MSGE -0.15
- NVAX 0.14
- Stochastic Oscillator
- MSGE 11.90
- NVAX 53.70
About MSGE Madison Square Garden Entertainment Corp.
Madison Square Garden Entertainment Corp provides live entertainment, delivering unforgettable experiences while forging deep connections with diverse and passionate audiences. The company's portfolio includes a collection of world-renowned venues - New York's Madison Square Garden, The Theater at Madison Square Garden, Radio City Music Hall, and Beacon Theatre; and The Chicago Theatre - that showcase a broad array of sporting events, concerts, family shows, and special events for millions of guests annually. In addition, the company features the original production, the Christmas Spectacular Starring the Radio City Rockettes, which has been a holiday tradition for 89 years.
About NVAX Novavax Inc.
Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. Novavax works together with its wholly owned Swedish subsidiary to produce vaccine candidates to respond to both known and emerging disease threats. The company believes its vaccine technology has the potential to be applied broadly to a wide variety of human infectious diseases. The Company manages its business as one operating segment, the development and commercialization of vaccines. The company generates maximum revenue from Europe.